The purpose of this email is to remind VFC-enrolled providers that the monoclonal antibody product nirsevimab (trade name Beyfortus® manufactured by Sanofi) will be available for ordering on Friday, August 1, 2025.
Topics Related to Immunization
We are writing to inform you of several changes to the Vaccines for Children (VFC) program policies that may affect your practice, effective July 1, 2025.
This email is to inform you of an important update to share regarding measles reporting, testing, and vaccination.
We’re excited to announce our Provider Lunch and Learn series, a new virtual educational offering from the North Carolina Immunization Program (NCIP).
This email is to inform you that the NC Immunization Program (NCIP) received guidance that the Centers for Disease Control and Prevention (CDC) has released updated versions of the Child and Adolescent and
Dear Partner,
The North Carolina Department of Health and Human Services launched a new interactive VFC provider map to help eligible North Carolina families more easily find free childhood vaccines in their area through the Vaccines for Children (VFC) program.